Proposing algal chloroplast as the new status quo for biopharmaceutical peptide production.

Developed a targeted gene therapy against B cell lymphoma through the use of a unique AAVP viral vector platform.

Developing an oral phage-based vaccine for the neglected tropical diseases echinococcosis and cysticercosis through the use of AAVP technology.

Combated adherent-invasive E. coli through a specialized genetic circuit as a potential therapeutic for inflammatory bowel disease.